Sample size determination for estimating antibody seroconversion rate under stable malaria transmission intensity

Abstract

BackgroundIn the last decade, several epidemiological studies have demonstrated the potential of using seroprevalence (SP) and seroconversion rate (SCR) as informative indicators of malaria burden in low transmission settings or in populations on the cusp of elimination. However, most of studies are designed to control ensuing statistical inference over parasite rates and not on these alternative malaria burden measures. SP is in essence a proportion and, thus, many methods exist for the respective sample size determination. In contrast, designing a study where SCR is the primary endpoint, is not an easy task because precision and statistical power are affected by the age distribution of a given population.MethodsTwo sample size calculators for SCR estimation are proposed. The first one consists of transforming the confidence interval for SP into the corresponding one for SCR given a known seroreversion rate (SRR). The second calculator extends the previous one to the most common situation where SRR is unknown. In this situation, data simulation was used together with linear regression in order to study the expected relationship between sample size and precision.ResultsThe performance of the first sample size calculator was studied in terms of the coverage of the confidence intervals for SCR. The results pointed out to eventual problems of under or over coverage for sample sizes ≤250 in very low and high malaria transmission settings (SCR ≤ 0.0036 and SCR ≥ 0.29, respectively). The correct coverage was obtained for the remaining transmission intensities with sample sizes ≥ 50. Sample size determination was then carried out for cross-sectional surveys using realistic SCRs from past sero-epidemiological studies and typical age distributions from African and non-African populations. For SCR < 0.058, African studies require a larger sample size than their non-African counterparts in order to obtain the same precision. The opposite happens for the remaining transmission intensities. With respect to the second sample size calculator, simulation unravelled the likelihood of not having enough information to estimate SRR in low transmission settings (SCR ≤ 0.0108). In that case, the respective estimates tend to underestimate the true SCR. This problem is minimized by sample sizes of no less than 500 individuals. The sample sizes determined by this second method highlighted the prior expectation that, when SRR is not known, sample sizes are increased in relation to the situation of a known SRR. In contrast to the first sample size calculation, African studies would now require lesser individuals than their counterparts conducted elsewhere, irrespective of the transmission intensity.ConclusionsAlthough the proposed sample size calculators can be instrumental to design future cross-sectional surveys, the choice of a particular sample size must be seen as a much broader exercise that involves weighting statistical precision with ethical issues, available human and economic resources, and possible time constraints. Moreover, i...

Ocular Chlamydia trachomatis infection, anti-Pgp3 antibodies and conjunctival scarring in Vanuatu and Tarawa, Kiribati before antibiotic treatment for trachoma

“…Because of the low seroprevalence, the seroreversion rate (SRR) was assumed to be 0 events per person per year, as demonstrated for seroepidemiological studies of malaria. 32 The model deployed corresponded to scenario 1 version 2 of the scenarios tested by Pinsent et al 31 Proportions were compared using Fisher's Exact Test. For small, non-parametric group comparisons (such as comparing the load of infection in those with or without TF in Vanuatu), Mann Whitney U tests were used.…”

Measuring changes in transmission of neglected tropical diseases, malaria, and enteric pathogens from quantitative antibody levels

“…A sample of 20 individuals is unlikely to provide accurate information about seroprevalence or seroconversion rates [6], but could provide a reliable estimate of mean antibody levels-the village-level analyses in the Garki project showed that use of P . falciparum quantitative antibodies led to larger and more precise estimates of differences between control and intervention groups than seroprevalence when estimated in small samples (S2 Fig).…”

Using health facility-based serological surveillance to predict receptive areas at risk of malaria outbreaks in elimination areas

“…The sample size calculation was performed using methods specific for estimating antibody seroconversion rates (SCR, i.e. the proportion of people in the population who are expected to seroconvert per year) [56]. The SCR to either P. falciparum apical membrane antigen 1 (PfAMA1) or merozoite surface protein 1 (PfMSP-1- 19 ) in Kulon Progo was expected to be lower than the SCR reported in the neighbouring pre-elimination setting, Purworejo District, Indonesia (SCR 0.019 (95% CI 0.015-0.022)).…”